Edwards Lifesciences Corp/ US28176E1082 /
| 18/11/2024 22:10:00 | Chg. +2.13 | Volume | Bid13:09:13 | Ask13:09:13 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 69.89USD | +3.14% | 7.06 mill. Turnover: 362.61 mill. |
67.10Bid Size: 100 | 71.00Ask Size: 500 | 41.22 bill.USD | - | 30.26 |
Assets
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 269.8000 | 304.3000 | 373.3000 | 421.6000 | 442.9000 | ||||||
| Intangible Assets | 67.1000 | 66.9000 | 67 | 57.2000 | 23.4000 | ||||||
| Long-Term Investments | - | - | - | - | 240.9000 | ||||||
| Fixed Assets | - | - | - | - | 1,229.7000 | ||||||
| Inventories | 203.6000 | 261.3000 | 281 | 308.9000 | 296.8000 | ||||||
| Accounts Receivable | 277.3000 | 283.8000 | 321.1000 | 302.5000 | 288 | ||||||
| Cash and Cash Equivalents | 396.1000 | 171.2000 | 310.9000 | 420.4000 | 653.8000 | ||||||
| Current Assets | 1,032.6000 | 1,168.5000 | 1,291.9000 | 1,725.8000 | 2,294.6000 | ||||||
| Total Assets | 1,767.2000 | 1,980.5000 | 2,221.5000 | 2,724.7000 | 3,524.3000 | ||||||
Liabilities
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 47.6000 | 85 | 74.7000 | 48.4000 | 58.2000 | ||||||
| Long-term debt | - | - | - | - | 598.1000 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 226.1000 | 234.8000 | 263.2000 | 297.2000 | 376.2000 | ||||||
| Liabilities | 459 | 642.6000 | 742.2000 | 1,165.5000 | 1,332.9000 | ||||||
| Share Capital | - | - | - | - | 257.8000 | ||||||
| Total Equity | 1,308.2000 | 1,337.9000 | 1,479.3000 | 1,559.2000 | 2,191.4000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 1,767.2000 | 1,980.5000 | 2,221.5000 | 2,724.7000 | 3,524.3000 | ||||||
Income Statement
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,447 | 1,678.6000 | 1,899.6000 | 2,045.5000 | 2,322.9000 | ||||||
| Depreciation (total) | - | - | - | - | 68.6000 | ||||||
| Operating Result | 261.6000 | 278.5000 | 392.4000 | 521.8000 | - | ||||||
| Interest Income | -1.5000 | .3000 | .4000 | -5.2000 | 10.8000 | ||||||
| Income Before Taxes | 268.2000 | 283.6000 | 391.1000 | 515.3000 | 1,144 | ||||||
| Income Taxes | 50.2000 | 46.9000 | 97.9000 | 123.6000 | 332.9000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 218 | 236.7000 | 293.2000 | 391.7000 | 811.1000 | ||||||
Per Share
Cash Flow
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 251.4000 | 314.5000 | 373.8000 | 472.7000 | 1,022.3000 | ||||||
| Cash Flow from Investing Activities | -61.5000 | -412.8000 | -90.5000 | -412.7000 | -633 | ||||||
| Cash Flow from Financing | -103.9000 | -135.2000 | -155.6000 | 34.9000 | -153 | ||||||
| Decrease / Increase in Cash | 62 | -224.9000 | 139.7000 | 109.5000 | 233.4000 | ||||||
| Employees | 7,000 | 7,800 | 8,200 | 8,600 | 9,100 | ||||||
